Abbreviations: AH, apparently healthy cats; CKD, chronic kidney disease; CWLVDA, conditions characterized by chronic weight loss, vomiting, diarrhea, and anorexia; HCM, nonobstructive hypertrophic cardiomyopathy; HCM/HOCM, combined HCM/HOCM cohort; HOCM, obstructive hypertrophic cardiomyopathy; IQR, interquartile range; LV, left ventricular; pHCM, preclinical hypertrophic cardiomyopathy.
Most studies derive from veterinary insurance reports, 1-5 cemetery 6 and necropsy records, 7 surveys, [8] [9] [10] clinical registries, 11 national research databases, 12 health screening, and 13 medical record reviews from primary 14, 15 and tertiary care 16 practices. Information from these sources is generally limited to prevalence data, that is, the percentage of deaths due to a disease or condition identified at a point in time.
However, insights regarding incidence, that is, the rate of new conditions arising in populations over time, are scarce; risk and survival comparisons for preclinical cohorts are largely unreported; and population effects related to age and cause-specific mortality remain uncertain.
The REVEAL study reported cardiovascular morbidity and survival in 1730 apparently healthy cats (AH) and cats with preclinical hypertrophic cardiomyopathy (pHCM). 17 To further our understanding of feline longevity, the present study aimed to identify the epidemiology of noncardiovascular and all-cause death and assess its overall impact on health in the same population. Specific objectives were to determine from medical records, the major causes of death, contrast incidence rates, risk, and survival characteristics, and compare these observations between susceptible populations and age groups over a prolonged period of time.
2 | MATERIALS AND METHODS
| Study design
Data were derived from an analysis of medical and demographic data collected for the REVEAL Study 17 project. Ethical review committee approval was obtained where required.
| Cats
Analysis included 1730 cats: 722 AH and 1008 pHCM (430 nonobstructive hypertrophic cardiomyopathy [HCM] and 578 obstructive hypertrophic cardiomyopathy [HOCM] ). 17 Enrolled cats had normal physical examination except for the presence of heart murmurs in some cats. No other known serious illness or medical history abnormalities were detected. All had echocardiographic examinations performed at the time of study entry. The study cohort of AH received echocardiographic examinations for preanesthetic workups, to evaluate cardiac status when heart murmurs were detected, as part of case recruitment of AH without significant heart disease for the present study, and for breed screening in certain pedigrees.
| Inclusion criteria
Each investigator had a searchable echocardiographic and medical record database permitting detailed review and long-term health follow-up.
Medical records were examined for cats diagnosed with either HCM or HOCM, and AH without cardiomyopathy, whose health outcomes could be ascertained for at least 5 years after the date of study entry. Archived echocardiographic images were reviewed to confirm diagnosis. Study entry was recorded as the date when echocardiographic examination was first performed. 17 
| Exclusion criteria
Any of the following conditions diagnosed at or before study entry resulted in study exclusion: congestive heart failure; arterial thromboembolism; syncope; heartworm disease; arterial hypertension (systolic arterial blood pressure ≥180 mm Hg); hyperthyroidism; anemia; chronic kidney disease (CKD), defined as any combination of serum creatinine concentration above laboratory reference interval, urine concentrating ability deemed to be inadequate or isosthenuria, proteinuria, and small, irregular kidneys; cardiomyopathy other than pHCM; congenital heart disease; cancer; any systemic, endocrine, hepatobiliary, pancreatic, or chronic gastrointestinal disease; and medical or surgical condition judged capable of limiting life expectancy.
| Study sites
Investigators participated from 50 veterinary centers in 21 countries. 17 
| Echocardiography
Cardiac diagnoses were confirmed from archived echocardiograms.
Left ventricular (LV) hypertrophy represented end-diastolic LV free wall and or interventricular wall thickness ≥6 mm. 18 Hypertrophic obstructive cardiomyopathy was defined as LV hypertrophy with systolic anterior motion of the mitral valve, diffuse LV outflow tract turbulence, and peak systolic outflow velocity ≥2.5 m/s, whereas HCM represented hypertrophic cardiomyopathy without LV outflow tract obstruction.
| Data collection and outcomes assessment
Medical records where the first echocardiographic examination was performed between November 2001 and January 2011 were reviewed to T A B L E 1 Recorded deaths in cats that at study entry were diagnosed as apparently healthy or with preclinical HCM/HOCM 3 | RESULTS
| Population characteristics at time of diagnosis
Study population demographic data were recently reported. 17 Briefly, median age of AH (4.9 years) was significantly younger than HCM (7.4 years; P < .001) and HOCM (5.7 years; P = .01) cohorts; HOCM were younger than HCM (P < .001) cohorts, and AH were also younger compared with the HCM/HOCM cohort (6.5 years; P < .001). Thirty-four breeds comprised the total population. Domestic Shorthair, Maine Coon cat, Persian, Domestic Longhair, and Norwegian Forest cat breeds were most prevalent. 
| Overall mortality

| Incidence
Mortality rates per 1000 cat-years were compared between cohorts defined by age quartile at the time of study entry and arranged by cause of death (Table 3) . Noncardiovascular mortality was similar between AH and HCM/HOCM cats; however, all-cause mortality was substantially higher in HCM/HOCM compared to AH due to cardiovascular death, which occurred frequently in HCM/HOCM cats but rarely in AH (Figure 1 ). Overall, noncardiovascular and all-cause mortality rates were lowest in the first 2 age quartiles and increased with age (Table 3, Figure 2 ). Specifically, incidence rates for noncardiovascular death in AH were slightly more than twice higher in both the second compared with the first age quartile and in the third compared with the second quartile, and 2.4 times higher in the fourth compared with the third age quartile; in HCM/HOCM cats, noncardiovascular mortality was 2 times higher in the second compared with the first quartile, 1.8 times higher in the third compared with the second quartile, and 2.6 times higher in the fourth compared with the third quartile.
For cause-specific mortality rates in AH, cancer death was 23.3 times higher in cats >10 years than in cats <2.5 years old; CKD death was 51 times higher in cats >10 than for cats <2.5 years; and CWLVDA death was 3 times higher in cats >10 than <2.5 years. In HCM/HOCM cats, cancer, CKD, and CWLVDA death rates also increased with age. Comparing their mortality rates between cats older than 10 years with cats younger than 2.5 years, cancer death was 6.3 times higher, CKD death was 27.2 times higher, and CWLVDA death was 14.3 times higher, respectively. In both AH and HCM/HOCM cohorts, CKD death incidence rate increased substantially with age, especially in the third and fourth age quartiles (Table 3 ).
| Risk
Risk of death due to noncardiovascular and all-cause mortalities increased variably at 1, 2.5, 5, 7.5, and 10-year intervals following The increment of risk for these mortalities was comparatively higher at 5 years compared with 10 years after study entry for AH and HCM/HOCM cats. Comparative risk of CKD death was greatest in cats that were in the fourth age quartile at study entry (Table 4 ).
| Survival analyses
Survival time from study entry to noncardiovascular death did not Figure 5 ). Survival curves for AH and HCM/HOCM cats stratified by age quartile at time of study entry diverged markedly for noncardiovascular ( Figure 6 ) and all-cause ( Figure 7) death, most notably for the second and third, and the third and fourth age quartiles. This was largely caused by cancer and CKD deaths ( Table 4 ). For example, at Figure 8C ).
| DISCUSSION
We identified noncardiovascular causes of death and examined all-cause mortality, incidence rates, risk, and survival characteristics in 1730 cats.
To the best of our knowledge, this represents the first long-term comparison of causes of death between populations that at study entry were initially healthy or had preclinical HCM/HOCM. Death from cancer, CKD and CWLVDA represented 75%-80% of noncardiovascular mortality in cats originating from around the world, confirming the major impact of these conditions on life expectancy. [1] [2] [3] [4] [5] [6] 8, [11] [12] [13] These findings complement the epidemiology of cardiovascular mortality reported from the same population. 17 In the present study, all-cause mortality was significantly greater and survival duration was significantly shorter in HCM/HOCM cats compared to AH, due to cardiovascular death that was substantial in HCM/HOCM cats but rare in AH.
Cancer was the most frequently recorded cause of noncardiovascular death. Apparently healthy cats and HCM/HOCM cats with cancer death did not differ significantly for age at study entry or for survival time. In AH compared with HCM/HOCM cats, the increment of cancer death risk was substantial by 5 years (1 in 9 and 1 in 14, respectively) compared with 1 year (1 in 36 and 1 in 50, respectively) after study entry. By comparison at 10 years after study entry, risk was 1 in 7 and 1 in 10, respectively.
Population-based data describing epidemiology of feline neoplasia are scant. Direct comparison with our findings is problematic due to diverse study populations, disparate inclusion criteria, and dissimilar methods for disease estimation. [19] [20] [21] [22] [23] Lymphoma is the most commonly reported feline neoplasm 20 and most prevalent form of gastrointestinal cancer. 24, 25 However, we did not attempt to document histological diagnoses in all cats whose deaths were attributed to cancer in our study.
Chronic kidney disease was the second most commonly recorded cause of noncardiovascular death. As with cancer, CKD death predominantly affected middle-aged and older cats. Similar to cancer, in both AH and HCM/HOCM cats, the increment of CKD death risk was greatest at to be a CKD risk factor. 26 In our study, sex ratio with CKD death was approximately 1.6 to 1 female-to-male in AH and 2.5 to 1 male-to-female in HCM/HOCM cats. However, heart disease was excluded in AH,
whereas HCM/HOCM is associated with strong male predilection, possibly explaining these differences.
Survival from study entry to CKD death was significantly shorter in HCM/HOCM cats compared with AH. Although age at study entry did not differ significantly between AH and HCM/HOCM cats with recorded CKD death, the HCM/HOCM cohort was significantly older than AH and might have introduced a population bias, because prevalence of CKD increases with age. 13, [26] [27] [28] [29] Consequently, we cannot resolve whether pHCM predisposed to acute kidney injury as a hypothesis for their shorter survival time to CKD death, compared with AH. This merits further study.
Death associated with CWLVDA was the third most commonly recorded cause of noncardiovascular death. Compared with cancer death, incidence rates were approximately one-third lower in AH and one-half lower in HCM/HOCM cats, respectively. Consistent with cancer and CKD death, the increment of risk for CWLVDA death in AH and HCM/HOCM cats was greatest at 5 years (approximately 1 in 30 and 1 in 29 respectively) compared with 1 year (1 in 143) after study entry. Middle-age predilection has been reported for feline inflammatory bowel disease, 1 of the most common feline enteropathies. 30, 31 In our study, the cohort of AH with recorded CWLVDA death were middle-aged at the time of study entry.
How best to apply epidemiology to promote disease detection and improve feline health remains a long-standing topic of interest, 13, 28, [32] [33] [34] [35] [36] [37] especially because current metrics to assess disease have limitations. Age categories are considerably subjective, as designated, for example, by middle-aged, adult, mature, senior, or geriatric labels that are commonly applied. Indeed, interpreting age-appropriate physical and physiologic aging changes may be ambiguous. Collectively, predicting risk based solely upon time from birth is indeterminate. [38] [39] [40] [41] Nonetheless, increased health screening has been routinely advocated for "older" cats, emphasizing medical history, physical examination, and laboratory testing as footings to detect illness. 28, [32] [33] [34] [35] [36] 42 Often, however, medical history and physical examination findings are vague or unremarkable. Furthermore, blood test variables might be unaffected, particularly in early disease stages and even when certain disease has progressed. 43 Laboratory reference intervals that reflect normal aging improves test acuity, 15 but available data are limited. Thus, screening clinical pathology test values frequently fall within normal reference intervals, 13 and normal findings might not reflect the state of health nor assure the absence of disease.
The present study reports survival characteristics, incidence rates, and mortality risk in feline populations that at study entry were apparently healthy or had pHCM. These methods afford a constructive approach to support healthcare planning, and our findings provide informative considerations for future screening programs. We prioritized analysis of incidence over prevalence in order to compare noncardiovascular, all-cause, and cause-specific mortality across age quartiles and betweenstudy populations. Most feline reports emphasize prevalence, 1-13 which describes the total number of cases in a study population at a single time point, but is affected by disease duration and occurrence, and is not well suited for monitoring disease trends. 44 Our study revealed that cancer, CKD, and CWLVDA death were the major causes of noncardiovascular death. Although older cats had the highest noncardiovascular mortality event rates, substantial mortality was also recorded in the middle 2 age quartiles, ages not customarily targeted for enhanced wellness screening.
We also observed that the greatest increment of risk for death caused by cancer, CKD, and CWLVDA occurred at 2.5 and 5 years compared with 1 year after study entry. The increment of risk for noncardiovascular death after study entry in AH and HCM/HOCM cats increased approximately 2.4 and 1.9 times at 2.5 years compared with 1 year, respectively, and increased further, by approximately 1.8 and 2.1 times at 5 years compared with 2.5 years after study entry, respectively. These findings might contribute to planning screening visits.
There were several important study limitations. As this was a retrospective study, it was not feasible to collect comprehensive test data, biopsy procedures, or necropsy results on every case, and we were not able to refine survival analyses according to histologic grading of cancer.
Although exclusionary criteria were imposed to screen out cases with obvious clinical illness, some diseases may have been undetected. Attributing cause of death in cases associated with gastrointestinal signs of disease can be difficult. Indeed, well-recognized challenges have been reported, including shifting and controversial classification systems, evolving terminology, unsettled diagnostic criteria, and uncertain test accuracy. 30 Distinguishing between inflammatory bowel disease and lymphoma, the 2 principal diseases affecting the feline gastrointestinal system is especially problematic and comorbidities may exist. [45] [46] [47] [48] [49] [50] [51] [52] Although cause of death was relegated to an "unknown category" whenever information was insufficient, misclassification of cause-specific death was possible. However, the broader categories of noncardiovascular and allcause death still provide meaningful bases for comparing populations and age quartiles. Referral bias might have been present at some study sites.
Moreover, some selection bias might have resulted because some AH were examined with echocardiography to assess a heart murmur for breeding examination or preanesthesia evaluation. It was not possible to assure that study populations represented endemic disease burdens in each geographic region. Thus, incidence rates might have been overrepresented or underrepresented at some sites. However, we are unaware of comprehensive survey data confirming geographic distribution of feline diseases. Our relatively large study population originating from varied geographical regions might have diminished these effects. We did not attempt to identify benefit or detriment of any drug treatment on the natural history of study populations or assess whether diet, genetic, or environmental factors influenced health and longevity 19, 49, 53 Moreover, we could not control for possible regional attitudes towards euthanasia that might have influenced survival. Finally, cardiac status was based on 1 initial echocardiographic examination at the point of study entry.
Limitations related to these factors have been detailed. 17 
| CONCLUSIONS
Notwithstanding these limitations, our study contributes new epidemiologic information about noncardiovascular and all-cause mortality, including incidence rates, risk, and survival outcomes in cats that at study entry were apparently healthy or had pHCM. The most commonly recorded noncardiovascular causes of death were cancer, followed by CKD, and then conditions characterized by CWLVDA. Although life spans of AH and pHCM cats that died from noncardiovascular causes were similar, pHCM conferred a substantial health burden over-and-above the risk for noncardiovascular death. All-cause mortality was significantly greater in pHCM due to cardiovascular death which was common in this cohort but rare in AH.
Noncardiovascular death approximately doubled every successive age quartile in AH and pHCM cats. Moreover, the increment of risk of noncardiovascular death was highest at 2.5 years compared with 1 year after study entry and 5 years compared with 2.5 years after study entry, respectively, approximately doubling at each comparative time point. Furthermore, increment of noncardiovascular risk was approximately 4 times higher at 5 years than at 1 year after study entry. Comparatively, this increment was higher than the increment of risk recorded 10 years versus 5 years after study entry. Still, although noncardiovascular mortality increased with advancing age, it was also notably present in middle-aged populations, cohorts that are often underemphasized in contemporary health screening guidelines.
Collectively, these findings add new epidemiologic information that may assist veterinarians anticipate potential health conditions, contribute to the future development of health care guidelines, and aid long-term surveillance and wellness monitoring strategies.
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